Search

Search Constraints

You searched for: Author/Creator Harlan, William

Search Results

1. All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study. Issue 4 (10th March 2015)

2. An Interactive Smoking Cessation Program Provides No Difference in Motivational Benefit Over Passive Materials in Crohn's Disease: 678. (October 2017)

3. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022)

4. S0668 Time to Improvement in Patient-Reported Outcomes With Tofactinib in Ulcerative Colitis: Initial Results From a Real World Prospective Multicenter Study (TOUR). (October 2020)

5. S931 Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR). (October 2021)